9 Results for "

Elacestrant

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Elacestrant" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-19822
CAS No.: 722533-56-4
Synonyms: RAD1901
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...
19
19 Publications Verification
Cat. No.: HY-19822A
CAS No.: 1349723-93-8
Synonyms: RAD1901 dihydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant (RAD1901) dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant dihydrochloride also can inhibit growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-19822D
CAS No.: 2309762-29-4
Synonyms: RAD1901 S enantiomer
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant S enantiomer (RAD1901 S enantiomer) is an low activity enantiomer of elacestrant. Elacestrant (RAD1901) is a selective and orally available estrogen receptor (ERR) degrader with IC50 values of 48 and 870 nM for ERα and ERβ, respectively .
loading...
    loading...
Cat. No.: HY-19822B
CAS No.: 2309762-30-7
Synonyms: RAD1901 S enantiomer dihydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride) is an low activity enantiomer of elacestrant dihydrochloride. Elacestrant (RAD1901) dihydrochloride is a selective and orally available estrogen receptor (ERR) degrader with IC50 values of 48 and 870 nM for ERα and ERβ, respectively.
loading...
    loading...
Cat. No.: HY-19822S
Synonyms: RAD1901-d4
Elacestrant-d4 (RAD1901-d4) is a deuterated labeled Elacestrant (HY-19822). Elacestrant (RAD1901) is a selective estrogen receptor (estrogen receptor, ER) degrader (SERD) with oral activity, with IC50 values of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant can also effectively inhibit the growth of ER + breast cancer cell lines both in vitro and in vivo.
loading...
    loading...
Cat. No.: HY-19822S2
Synonyms: RAD1901-d10
Elacestrant-d10 is the deuterium labeled of Elacestrant (HY-19822). Elacestrant is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also inhibits growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-19822S3
Synonyms: RAD1901-d6
Elacestrant-d6 (RAD1901-d6) is a deuterated labeled Elacestrant (HY-19822). Elacestrant is a selective estrogen receptor (estrogen receptor, ER) degrader (SERD) with oral activity, with IC50 values of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant can also effectively inhibit the growth of ER + breast cancer cell lines both in vitro and in vivo.
loading...
    loading...
Cat. No.: HY-19822S1
Synonyms: RAD1901-d4-1
Elacestrant-d4-1 is the deuterium labeled Elacestrant (HY-19822). Elacestrant is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively .
loading...
    loading...
Cat. No.: HY-19822S4
Synonyms: RAD1901-d5
Elacestrant-d5 (RAd1901-d5) is the deuterium labeled Elacestrant (HY-19822). Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...